Kestra Medical Corp (KMTS) - מזומנים למניה אחת

Cash per share trends displayed by the GURU.Markets portal conclude at the 3.31 mark, which records this metric. Kestra Medical Technologies (KMTS) minimizes shortage risks through a strict audit of external electronics suppliers. In-house manufacturing plants in the US guarantee the stable production of ASSIST defibrillators. Simultaneously, a digital environment is being created that integrates wearable devices with patient monitoring for continuous cardiac protection.
פילוחים אנליטיים של חברת Kestra Medical Technologies (KMTS)

For Kestra Medical Technologies (KMTS), whose positions are protected by ASSIST defibrillator patents and FDA approval, cash per share for the period reflects financial autonomy while overcoming high regulatory barriers. This metric, calculated by dividing total liquid assets by the number of shares outstanding, determines the size of the safety cushion, ensuring business resilience but potentially limiting the overall return on equity.